Login
From:
Neuromyelitis News
(Uncensored)
subscribe
Long-term rituximab lowers NMOSD relapse risk, eases disability
https://neuromyelitisnews.com/news/long-term-rituximab-lowers-nmosd-relapse-risk-eases-disability/
links
backlinks
Tagged with:
rituximab
low dose rituximab
Off-label rituximab significantly reduces the risk of relapse and lessens disability in most NMOSD patients, a long-term study showed.
Roast topics
Find topics
Find it!
